​

NextCure (NXTC) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

NXTC Stock Forecast

NextCure (NXTC) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $15.00 and a low of $15.00. This represents a 10.29% increase from the last price of $13.60.

- $3 $6 $9 $12 $15 High: $15 Avg: $15 Low: $15 Last Closed Price: $13.6

NXTC Stock Rating

NextCure stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 1 Hold (7.69%), 1 Sell (7.69%), and 0 Strong Sell (0.00%).

Buy
Total 13 1 1 11 0 Strong Sell Sell Hold Buy Strong Buy

NXTC Price Target Upside V Benchmarks

TypeNameUpside
StockNextCure10.29%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$15.00
Last Closing Price$13.60$13.60$13.60
Upside/Downside--10.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2612---3
Feb, 2612---3
Jan, 2612---3
Dec, 2512---3
Nov, 252-1--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 15, 2025Edward TenthoffPiper Sandler$15.00$4.76215.13%10.29%
Jun 03, 2024Edward TenthoffPiper Sandler$3.00$1.5297.37%-77.94%
Nov 03, 2022Edward TenthoffPiper Sandler$6.00$2.51139.04%-55.88%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 15, 2025Piper SandlerOverweightOverweighthold
Jun 03, 2024Piper SandlerOverweightOverweighthold
Nov 03, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.04$-23.88$-19.65---
Avg Forecast$-2.28$-1.92$-1.45$-0.62$-0.50$-0.47
High Forecast$-2.22$-1.82$-1.39$-0.62$-0.50$-0.47
Low Forecast$-2.33$-1.99$-1.53$-0.62$-0.50$-0.47
Surprise %1085.96%1143.75%1255.17%---

Revenue Forecast

$3M $5M $6M $8M $9M $11M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$3.30M$7.00M$10.60M
High Forecast---$3.30M$7.00M$10.60M
Low Forecast---$3.30M$7.00M$10.60M
Surprise %------

Net Income Forecast

$-65M $-54M $-43M $-32M $-21M $-10M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.72M$-55.65M$-55.84M---
Avg Forecast$-62.72M$-53.02M$-40.85M$-17.26M$-13.92M$-13.08M
High Forecast$-61.67M$-50.74M$-38.68M$-17.26M$-13.92M$-13.08M
Low Forecast$-64.74M$-55.30M$-42.61M$-17.26M$-13.92M$-13.08M
Surprise %-4.96%36.71%---

NXTC Forecast FAQ

Is NextCure stock a buy?

NextCure stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that NextCure is a favorable investment for most analysts.

What is NextCure's price target?

NextCure's price target, set by 13 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $15 at the low end to $15 at the high end, suggesting a potential 10.29% change from the previous closing price of $13.6.

How does NextCure stock forecast compare to its benchmarks?

NextCure's stock forecast shows a 10.29% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for NextCure over the past three months?

  • March 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NextCure’s EPS forecast?

NextCure's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.62, marking a -96.84% decrease from the reported $-19.65 in 2025. Estimates for the following years are $-0.5 in 2027, and $-0.47 in 2028.

What is NextCure’s revenue forecast?

NextCure's average annual revenue forecast for its fiscal year ending in December 2026 is $3.3M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $7M, and $10.6M for 2028.

What is NextCure’s net income forecast?

NextCure's net income forecast for the fiscal year ending in December 2026 stands at $-17.259M, representing a -69.09% decrease from the reported $-55.844M in 2025. Projections indicate $-13.918M in 2027, and $-13.083M in 2028.